Stock WINT WINDTREE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Real-time Estimate Cboe BZX
Other stock markets
 12:46:08 2024-04-25 pm EDT 		5-day change 1st Jan Change
5.19 USD +0.68% Intraday chart for Windtree Therapeutics, Inc. -15.96% -60.28%
Apr. 16 Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 11 North American Morning Briefing : Stock Futures -2- DJ

Evolution of the average Target Price on Windtree Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fd4880fc501f.KxJTWzhsgg9gt0vrEF9wI-C0mAtmjhD5VFCpagxUcxU.fmsZNnkJ-l8P2AGHKTgcWqv84WZf1miIExbMXVUdB0Jtdjs1difMIlXUAg~8e8c12d8364e94347fbff5c11776729a

Analyst Recommendations on Windtree Therapeutics, Inc.

WINDTREE THERAPEUTICS : Oppenheimer Starts Windtree Therapeutics at Outperform with $8 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
5.155 USD
Average target price
18 USD
Spread / Average Target
+249.18%
High Price Target
18 USD
Spread / Highest target
+249.18%
Low Price Target
18 USD
Spread / Lowest Target
+249.18%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Windtree Therapeutics, Inc.

Oppenheimer

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. WINT Stock
  4. Consensus Windtree Therapeutics, Inc.